Use of xanthine derivatives to reduce the pathological and hyperactivity of the eosinophilic granulocyte, novel xanthine derivatives for reducing the pathological hyperreactivity of eosinophilic granulocytes, novel xanthine compounds and processes for producing them,

摘要

The present invention relates to tertiary 1-(hydroxyalkyl)-4-alkylxanthines suitable for the manufacture of medicaments for the treatment of disorders associated with pathologically increased responsiveness of the eosinophilic granulocytes. The present invention also relates to novel xanthine derivatives and processes for their preparation.